Lyrica and gabapentin
Pro Research Analysisby 
Searched over 200M research papers
Lyrica and Gabapentin: Mechanisms, Uses, and Comparative Insights
Mechanisms of Action: Calcium Channel Alpha2-Delta Ligands
Gabapentin (Neurontin) and Pregabalin (Lyrica) are structurally and mechanistically distinct from other analgesics. They are not GABAergic but instead reduce the stimulated release of neurotransmitters by binding to the calcium channel alpha2-delta (CaVa2-d) proteins1. This binding reduces neurotransmitter release in neuronal tissue, which is crucial for their therapeutic effects in pain and seizure control5 6. Additionally, these drugs may interact with other proteins such as N-methyl-D-aspartate-sensitive glutamate receptors, neurexin-1α, and thrombospondins, contributing to their analgesic properties5.
Clinical Applications: Pain, Seizures, and Anxiety
Both gabapentin and pregabalin are approved for treating various conditions. Gabapentin was initially approved for seizure disorders, while pregabalin has broader approvals, including for diabetic neuropathy, postherpetic neuralgia, and fibromyalgia3. Pregabalin is also approved for anxiety disorders in Europe9. These drugs are particularly effective in treating neuropathic pain, a condition that is challenging to manage with traditional analgesics8.
Comparative Efficacy: Pregabalin vs. Gabapentin
Potency and Cost
Pregabalin is considered more potent than gabapentin, which is reflected in its classification as a Schedule V medication by the US Drug Enforcement Administration. However, pregabalin is significantly more expensive, with no generic formulation available, making gabapentin a more cost-effective option for many patients3.
Benzodiazepine Reduction
Pregabalin has shown a greater ability to reduce benzodiazepine use compared to gabapentin. In a study using the Norwegian Prescription Database, psychiatric patients who started pregabalin reduced their benzodiazepine use by 48%, compared to only 14% for those who started gabapentin2. This suggests that pregabalin may have superior anxiolytic effects.
Combined Use for Pain Control
Despite their similarities, gabapentin and pregabalin can be used in combination for pain control. This combined approach can enhance therapeutic response and reduce the dose and side effects of each drug. However, pharmacokinetics, drug interactions, and adverse reactions must be carefully considered before adopting combination therapy4.
Conclusion
Gabapentin and pregabalin are valuable drugs for managing chronic pain, seizures, and anxiety disorders. Their primary mechanism involves binding to the calcium channel alpha2-delta subunits, reducing neurotransmitter release. While pregabalin is more potent and effective in reducing benzodiazepine use, it is also more expensive. Both drugs can be used in combination to enhance pain control, but careful consideration of pharmacokinetics and potential interactions is necessary.
Sources and full results
Most relevant research papers on this topic
Mechanisms of analgesia by gabapentin and pregabalin – Calcium channel α2-δ [Cavα2-δ] ligands
Gabapentin and pregabalin reduce chronic pain by binding to calcium channel alpha2-delta proteins, not GABAergic, and reducing stimulated transmitter release.
Very Rigorous Journal
Highly CitedDoes Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
Pregabalin can help some patients significantly reduce their use of benzodiazepines, with psychiatric patients able to reduce their benzodiazepine use by 48% after starting pregabalin treatment.
Observational StudyUse of gabapentin and pregabalin for hand surgery patients.
Pregabalin is more potent and expensive than gabapentin, but both medications can effectively treat acute postoperative and chronic neuropathic pain in hand surgery patients.
Is there a role for combined use of gabapentin and pregabalin in pain control? Too good to be true?
Combining gabapentin and pregabalin shows potential in pain control, reducing doses and side effects while enhancing therapeutic response.
Analgesia with Gabapentin and Pregabalin May Involve N-Methyl-d-Aspartate Receptors, Neurexins, and Thrombospondins
Gabapentin and pregabalin's analgesic effects may involve interactions with N-methyl-d-aspartate receptors, neurexin-1, and thrombospondins, in addition to voltage-gated calcium channels.
Amperometric Measurement of Glutamate Release Modulation by Gabapentin and Pregabalin in Rat Neocortical Slices: Role of Voltage-Sensitive Ca2+ α2δ-1 Subunit
Gabapentin and pregabalin reduce stimulus-evoked glutamate release in rat neocortical slices, with the 2-1 subunit of VSCC playing a key role in this effect.
In Vitro StudyHighly CitedDrugging the undruggable: gabapentin, pregabalin and the calcium channel α2δ subunit
Using the sequence of a protein to predict other "druggable" proteins can lead to the development of new drugs with similar activities to existing ones, such as gabapentin and pregabalin.
Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.
Pregabalin's analgesic effects are mediated through the alpha2-delta-1 subunit of voltage-dependent calcium channels, making it a potential therapeutic target for pain control.
Highly CitedPharmacology and mechanism of action of pregabalin: The calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery
Pregabalin reduces neuronal excitability and seizures by binding to the alpha2–delta subunit of voltage-gated calcium channels, potentially through reduced neurotransmitter release.
Highly CitedPharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
Pregabalin reduces neuronal excitability and seizures by binding to alpha2-delta subunits in calcium channels, potentially through reduced neurotransmitter release.
Highly Cited